Key result
Endomyocardial biopsy in a 70-year-old man with new-onset heart failure established the diagnosis of giant cell myocarditis and led to successful immunosuppressive therapy.
Why the study?
Giant cell myocarditis is a rare autoimmune myocarditis with high morbidity and mortality that mainly affects middle-aged adults, making its diagnosis in older patients challenging.
Case Report (n=1)
A low threshold for endomyocardial biopsy in new onset heart failure can lead to actionable information and favorable outcomes even in older patients.
Authors
No takes yet. Share an insight, caveat, or question.
Biopsy may enable targeted immunosuppression in select elderly new-onset HF; single case leaves broader role open.
Dusík et al. (2020) conducted a case report in Giant cell myocarditis (n=1). Endomyocardial biopsy and immunosuppressive therapy was evaluated on Diagnosis and clinical outcome. Endomyocardial biopsy in a 70-year-old man with new-onset heart failure established the diagnosis of giant cell myocarditis and led to successful immunosuppressive therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: